Washington, D.C.–(Newsfile Corp. – January 13, 2025) – mctlaw has filed a lawsuit in the United States Court of Federal Claims (Case No. 25-15 L) on behalf of a Pittsburgh property owner, Rebecca Shaffer, seeking compensation for financial losses resulting from the Centers for Disease Control’s COVID-19 eviction moratorium. The moratorium, enacted during the pandemic, prohibited landlords from evicting tenants unable to pay rent due to financial hardships. The case is assigned to Judge Philip S. Hadji.
Federal Takings Claim Alleges Financial Losses for Rental Property Owners
According to the lawsuit, the CDC’s eviction moratorium prevented Ms. Shaffer from evicting a non-paying tenant and renting the property to a paying tenant for nearly 10 months. The lawsuit contends that the moratorium amounted to a federal takings claim under the Fifth Amendment of the U.S. Constitution, which prohibits the government from taking private property for public use without just compensation.
mctlaw asserts that the federal government’s policy resulted in significant financial losses for Ms. Shaffer, including lost rental income caused during the moratorium period.
The lawsuit seeks:
mctlaw emphasizes that this case does not challenge the CDC’s authority to implement the eviction moratorium or its public health objectives. Instead, it seeks fair compensation for property owners impacted by the policy.
For additional information, please contact mctlaw at (941) 348-2175 or amm@mctlaw.com.
About mctlaw
National law firm representing people in the following areas: Vaccine injury compensation in the VICP, mass torts for medical product liability, defective medical devices and drugs, kratom wrongful death, Depo-Provera lawsuits, GLP-1 litigation, metal on metal hip lawsuits, federal takings claims, and representing Native American Indian tribes.
Press Inquiries
mctlaw
https://www.mctlaw.com
Gilda Dennis
gdennis@mctlaw.com
(941) 979-9913
Washington, D.C. Office
1015 15th Street Northwest
Suite 1125
Washington, DC 20005
Florida Office
1515 Ringling Blvd.
Suite 700
Sarasota, FL 34236
Seattle Office 1325 4th Avenue
Suite 1730
Seattle, WA 98101
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/236828
Marlborough, Massachusetts--(Newsfile Corp. - January 14, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes LONDON,…
PALO ALTO, CALIFORNIA / ACCESSWIRE / January 14, 2025 / Bioz, Inc., a leader in…
BETHESDA, Md., Jan. 13, 2025 /PRNewswire/ -- RespondHealth, a real-world evidence (RWE) clinical discovery company, is…
The credit facility will fuel further AI product development, sales capacity, and M&A SAN FRANCISCO,…
Collaboration Will Enhance Strategic and Digital Communications and Engagement to Combat Human Trafficking RESTON, Va.,…